Vacirca Jeff L Insider Trading Activity (CAI)

Summary

Updated Jul 16, 2026

Vacirca Jeff L has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $501K.

Profile

Jeff L Vacirca is identified in the latest SEC filing as a director of Caris Life Sciences, Inc. as of May 12, 2026. The filing confirms the role but does not provide additional biographical details such as education, career history, or prior board memberships. There is no public indication from the filing that he is deceased.

Role	Director
Notability	25/100

Board memberships

Caris Life Sciences, Inc.

Awards & honors

Listed as a director of Caris Life Sciences, Inc. in SEC filings as of 2026-05-12.

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-05-12	CAI	Caris Life Sciences, Inc.	P — Open-market purchase	31.1K	$16.15	$501K
2026-02-27	CAI	Caris Life Sciences, Inc.	A — Grant or award	2.5K	$20.06	$50K

Frequently Asked Questions

Who is Vacirca Jeff L?

How many SEC Form 4 filings has Vacirca Jeff L submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Vacirca Jeff L been buying or selling stock?

Recorded transactions: 1 open-market purchases ($501K) and 0 open-market sales () across all tracked filings.

Where can I see all of Vacirca Jeff L's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Vacirca Jeff L — SEC Form 4 Insider Trading Activity